mTOR inhibitor WYE-23 is a mTOR inhibitor, and IC50 is 0.45 nM. It is selective to PI3Kα and IC50 is 661 nM. mTOR inhibitor WYE-23 has antitumor activity[1][2].

mTOR inhibitor-18 (Example 106) is a mTOR inhibitor. mTOR inhibitor-18 can be used for mTOR related research, such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders[1].

Mtor Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mtor gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mtor Rat Pre-designed siRNA Set A contains three designed siRNAs for Mtor gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTPAP Human Pre-designed siRNA Set A contains three designed siRNAs for MTPAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTPN Human Pre-designed siRNA Set A contains three designed siRNAs for MTPN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTR Human Pre-designed siRNA Set A contains three designed siRNAs for MTR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTREX Human Pre-designed siRNA Set A contains three designed siRNAs for MTREX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTRF1 Human Pre-designed siRNA Set A contains three designed siRNAs for MTRF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTRF1L Human Pre-designed siRNA Set A contains three designed siRNAs for MTRF1L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTRR Human Pre-designed siRNA Set A contains three designed siRNAs for MTRR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTSS1 Human Pre-designed siRNA Set A contains three designed siRNAs for MTSS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTSS2 Human Pre-designed siRNA Set A contains three designed siRNAs for MTSS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTTC is a 1,2,3-thiadiazole compound that exhibits mechanism-based inactivation, resulting in the inactivation of cytochrome P450 2E1 activity[1].

MTTP Human Pre-designed siRNA Set A contains three designed siRNAs for MTTP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mttp Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mttp gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mttp Rat Pre-designed siRNA Set A contains three designed siRNAs for Mttp gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTURN Human Pre-designed siRNA Set A contains three designed siRNAs for MTURN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTUS1 Human Pre-designed siRNA Set A contains three designed siRNAs for MTUS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTUS2 Human Pre-designed siRNA Set A contains three designed siRNAs for MTUS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTX1 Human Pre-designed siRNA Set A contains three designed siRNAs for MTX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTX2 Human Pre-designed siRNA Set A contains three designed siRNAs for MTX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MTX3 Human Pre-designed siRNA Set A contains three designed siRNAs for MTX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC1 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC12 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC13 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC15 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC16 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC17 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC19 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC2 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC20 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC21 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC22 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC3A Human Pre-designed siRNA Set A contains three designed siRNAs for MUC3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC4 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC5AC Human Pre-designed siRNA Set A contains three designed siRNAs for MUC5AC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC5B Human Pre-designed siRNA Set A contains three designed siRNAs for MUC5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC6 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC7 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUC8 Human Pre-designed siRNA Set A contains three designed siRNAs for MUC8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUCL1 Human Pre-designed siRNA Set A contains three designed siRNAs for MUCL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MUL1 Human Pre-designed siRNA Set A contains three designed siRNAs for MUL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

The occurrence of diseases is often associated with multiple targets and pathways, and the factors of disease formation are complex and diverse, so the development of more powerful drugs is needed. According to statistics, 21% of the FDA-approved drugs in 2015-2017 were multi-target compounds. Multi-target compounds refer to a drug targeting multiple disease-related targets or […]